Pfizer and BioNTech mRNA shingles vaccine study begins
A Phase I/II trial for the first mRNA-based shingles vaccine programme has been initiated by Pfizer Inc. and BioNTech SE.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
